Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Hanekom

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
Nature Biotechnology|May 26, 2015
COMPASS identifies T-cell subsets correlated with clinical outcomesLin Lin, Greg Finak, Kevin Ushey, et al.
Plos One|September 17, 2013
Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan AfricaJayne S Sutherland, Maeve K Lalor, Gillian F Black, et al.
Cell Host & Microbe|February 5, 2022
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escapeSandile Cele, Farina Karim, Gila Lustig, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunitySandile Cele, Farina Karim, Gila Lustig, et al.
Nature Communications|August 10, 2022
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infectionKhadija Khan, Farina Karim, Yashica Ganga, et al.
Nature Communications|March 16, 2024
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiationFarina Karim, Catherine Riou, Mallory Bernstein, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variantKhadija Khan, Farina Karim, Sandile Cele, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
Nature Biotechnology|May 26, 2015
COMPASS identifies T-cell subsets correlated with clinical outcomesLin Lin, Greg Finak, Kevin Ushey, et al.
Plos One|September 17, 2013
Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan AfricaJayne S Sutherland, Maeve K Lalor, Gillian F Black, et al.
Cell Host & Microbe|February 5, 2022
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escapeSandile Cele, Farina Karim, Gila Lustig, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunitySandile Cele, Farina Karim, Gila Lustig, et al.
Nature Communications|August 10, 2022
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infectionKhadija Khan, Farina Karim, Yashica Ganga, et al.
Nature Communications|March 16, 2024
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiationFarina Karim, Catherine Riou, Mallory Bernstein, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variantKhadija Khan, Farina Karim, Sandile Cele, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Pageof 9